Enhancing Antibody Discovery with Efficient Workflows
In the fast-evolving field of antibody discovery, the handling and management of B cells are critical to success. Xtalks is hosting a free webinar titled
"Avoid Post-FACS Sorting Delays: Choosing the Best Single B Cell Workflow for Antibody Discovery", aimed at providing valuable insights into optimizing the processes involved in B cell sorting and further antibody development.
The Importance of Single B Cell Sorting
Single B cell platforms are revolutionizing how researchers isolate and screen B cells specific to antigens. This method ensures that the crucial native heavy and light chain pairing necessary for proper antibody function is maintained. Among the existing techniques,
FACS (Fluorescence-Activated Cell Sorting) guided sorting excels due to its ability to deliver high precision and throughput. This makes it an attractive option for researchers who require both speed and selectivity in their antibody discovery programs.
During this engaging session, attendees will learn about different methodologies available for managing post-sorting workflows. Specifically, they will explore the differences between B cell culture-based workflows and recombinant antibody expression methods.
Workflow Decisions Post-Sorting
Once B cells have been sorted, researchers must decide between continuing through traditional B cell culture to recover naturally expressed antibodies or leveraging modern molecular biology techniques to move immediately to recombinant antibody expression. While both approaches have been proven effective, understanding their unique advantages and alignments with specific project goals and timelines is key to maximizing efficiency.
The webinar will feature hands-on case studies comparing the two approaches. Attendees will be walked through practical decision-making frameworks that can inform their strategy, covering aspects such as desired throughput, recovery rates, and applicable timelines. This knowledge is crucial for ensuring researchers don’t waste time on unnecessary steps that could hinder the research process.
Xtalks’ expert speakers will provide a detailed examination of the implications of choosing one pathway over another, helping attendees make informed decisions that can boost the efficiency and success of their antibody discovery initiatives.
Real-World Applications and Insights
To punctuate the theoretical knowledge presented, there will also be real-world data shared regarding success rates and timelines associated with both the culture-based and recombinant expression methods. This evidence will help researchers gauge the practicality of each methodology in relation to their specific objectives.
By the end of the session, participants will possess a clearer framework to confidently select the most suitable post-sorting strategy tailored to their unique discovery goals and timeframes. Whether engaged in early-stage discovery, conducting translational research, or developing antibody platforms, the insights shared during this webinar will be invaluable.
Event Details and Registration
The live webinar will be conducted on
Thursday, June 11, 2026, with broadcasts at
1 PM EDT (10 AM PDT) and
Friday, June 12, 2026, at
2 PM BST (3 PM CEST). To participate, interested individuals can register at the Xtalks website. The webinar promises to equip attendees with actionable strategies and knowledge crucial for improving their workflows and ultimately enhancing the success of their antibody discovery projects.
In summary, join us for this informative webinar and discover how to optimize your approaches in single B cell workflows, ensuring your research operates at its fullest potential.
For more information and to register, visit
Xtalks.
ABOUT XTALKS
Xtalks serves as a comprehensive platform for professionals in the life sciences, offering knowledge, insights, and networking opportunities to advance the field. From news and features to webinars and expert interviews, Xtalks aims to keep the community well-informed and prepared for emerging challenges and innovations in the industry.